EQUITY METHOD INVESTMENT AND NOTE RECEIVABLE - Schedule of Financial Information (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Schedule of Equity Method Investments [Line Items]
Gross profit	$ 2,371	$ 2,314	$ 2,284	$ 1,916	$ 2,012	$ 1,994	$ 1,801	$ 1,620	$ 8,885	$ 7,427
Income (loss) from continuing operations									1,605	2,261	$ 1,883
Net income (loss)									1,955	13,200	3,230
Net income (loss) attributable to shareholders	$ 996	$ 329	$ 501	$ 142	$ 744	$ 9,352	$ 792	$ 2,331	1,968	13,219	$ 3,231
Equity Method Investment, Nonconsolidated Investee or Group of Investees | Copeland
Schedule of Equity Method Investments [Line Items]
Net sales									4,323	1,677
Gross profit									1,495	479
Income (loss) from continuing operations									(326)	(442)
Net income (loss)									(326)	(442)
Net income (loss) attributable to shareholders									$ (322)	$ (442)